2D-BioPAD & MUNASET team up again at Graphene Week 2026
For the third consecutive year, the 2D-BioPAD and MUNASET projects are joining forces at Graphene Week 2026 to...
Read more
Supple Graphene Bio-Platform for point-of-care early detection and monitoring of Alzheimer’s Disease.
Learn moreIn a Nutshell
2D-BioPAD is pioneering a graphene-based Point-of-Care (PoC) In-Vitro Diagnostics (IVD) system for early Alzheimer’s Disease (AD) detection. This non-invasive solution, using 2D materials, can identify and quantify up to 5 AD biomarkers in real-time. Clinical pilot studies in Finland, Greece, and Germany aim to demonstrate its impact, with a focus on safety, ethics, and seamless integration into primary healthcare settings.
Latest News
2D-BioPAD at Graphene 2026 in Barcelona
From 30 June to 3 July 2026, the 2D-BioPAD project participated in Graphene 2026, held in Barcelona, Spain....
Read more
2D-BioPAD presented at the Hybrid Scientific Symposium on Dementia Prevention
Our partner Alzheimer Hellas, together with the Panhellenic Institute of Neurodegenerative Diseases and the School of Medicine of...
Read more
2D-BioPAD at the Kuopio Neuroscience 50 Years Symposium
2D-BioPAD was proudly presented at the Kuopio Neuroscience 50 Years Symposium, a landmark event celebrating five decades of...
Read more
Consortium Partners
